Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33684925

Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2021 Jul 1
First author
Lowe EJ

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Jul 1;137(26):3581-3582. doi: 10.1182/blood.2021011572.
    note
    Source null
    related pmid
    34196680
    relationship
    Comment in
  2. citation
    Blood. 2022 Apr 28;139(17):2726. doi: 10.1182/blood.2021013466.
    note
    Source null
    related pmid
    35482341
    relationship
    Erratum in

Authors and identifiers

  1. name
    Lowe EJ
    type
    Author
  2. name
    Reilly AF
    type
    Author
  3. name
    Lim MS
    type
    Author
  4. name
    Gross TG
    type
    Author
  5. name
    Saguilig L
    type
    Author
  6. name
    Barkauskas DA
    type
    Author
  7. name
    Wu R
    type
    Author
  8. name
    Alexander S
    type
    Author
  9. name
    Bollard CM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Lowe EJ
    type
    Author
  2. name
    Reilly AF
    type
    Author
  3. name
    Lim MS
    type
    Author
  4. name
    Gross TG
    type
    Author
  5. name
    Saguilig L
    type
    Author
  6. name
    Barkauskas DA
    type
    Author
  7. name
    Wu R
    type
    Author
  8. name
    Alexander S
    type
    Author
  9. name
    Bollard CM
    type
    Author
bibliography ids
  1. nci-bib-d3b8884f1e48c655b116822f
book metadata
content sha256
b4c15ab1ddbafcc691bc56a73c375be0648731c0ceba2a83dd8478d7a7fc4cd2
document type
citation
dois
  1. 10.1182/blood.2020009806
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:33684925
immutable id
pubmed:33684925@b4c15ab1ddbafcc691bc56a73c375be0648731c0ceba2a83dd8478d7a7fc4cd2
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
26
name
Blood
nlm unique id
7603509
pages
3595-3603
volume
137
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Jul 1;137(26):3581-3582. doi: 10.1182/blood.2021011572.
    note
    Source null
    related pmid
    34196680
    relationship
    Comment in
  2. citation
    Blood. 2022 Apr 28;139(17):2726. doi: 10.1182/blood.2021013466.
    note
    Source null
    related pmid
    35482341
    relationship
    Erratum in
outcomes validated
false
pmid
33684925
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
9470c4af23fa53fd8e7d3f85c86a17d19a1af0fcfd002bde31eb39a895b7e32c
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Jul 1
precision
day
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33684925/
title
Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1.

Preserved source evidence · Not medical advice